JP2023500873A5 - - Google Patents
Info
- Publication number
- JP2023500873A5 JP2023500873A5 JP2022525700A JP2022525700A JP2023500873A5 JP 2023500873 A5 JP2023500873 A5 JP 2023500873A5 JP 2022525700 A JP2022525700 A JP 2022525700A JP 2022525700 A JP2022525700 A JP 2022525700A JP 2023500873 A5 JP2023500873 A5 JP 2023500873A5
- Authority
- JP
- Japan
- Prior art keywords
- virus particles
- salt
- virus
- ionic surfactant
- nonionic surfactant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025052605A JP2025092571A (ja) | 2019-11-07 | 2025-03-26 | 低減した粒度を有するウイルスワクチンを生成するための組成物および方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962931909P | 2019-11-07 | 2019-11-07 | |
| US62/931,909 | 2019-11-07 | ||
| PCT/IB2020/000961 WO2021090067A2 (en) | 2019-11-07 | 2020-11-06 | Compositions and methods for producing a viral vaccine with reduced particle size |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025052605A Division JP2025092571A (ja) | 2019-11-07 | 2025-03-26 | 低減した粒度を有するウイルスワクチンを生成するための組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023500873A JP2023500873A (ja) | 2023-01-11 |
| JP2023500873A5 true JP2023500873A5 (https=) | 2023-11-02 |
Family
ID=74104121
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022525700A Pending JP2023500873A (ja) | 2019-11-07 | 2020-11-06 | 低減した粒度を有するウイルスワクチンを生成するための組成物および方法 |
| JP2025052605A Pending JP2025092571A (ja) | 2019-11-07 | 2025-03-26 | 低減した粒度を有するウイルスワクチンを生成するための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025052605A Pending JP2025092571A (ja) | 2019-11-07 | 2025-03-26 | 低減した粒度を有するウイルスワクチンを生成するための組成物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230220356A1 (https=) |
| EP (1) | EP4054630A2 (https=) |
| JP (2) | JP2023500873A (https=) |
| KR (1) | KR20220098370A (https=) |
| CN (1) | CN114929270A (https=) |
| AU (1) | AU2020380604A1 (https=) |
| BR (1) | BR112022008711A2 (https=) |
| CL (2) | CL2022001176A1 (https=) |
| IL (1) | IL292699A (https=) |
| MX (1) | MX2022005513A (https=) |
| WO (1) | WO2021090067A2 (https=) |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4064232A (en) * | 1974-01-14 | 1977-12-20 | Sandoz Ltd. | Process for isolating the immunogenic components of influenza viruses |
| TW570803B (en) * | 1997-04-09 | 2004-01-11 | Duphar Int Res | Influenza vaccine |
| PL355287A1 (en) | 1999-09-24 | 2004-04-05 | Smithkline Beecham Biologicals S.A. | Intranasal influenza virus vaccine |
| GB0024089D0 (en) | 2000-10-02 | 2000-11-15 | Smithkline Beecham Biolog | Novel compounds |
| CA2438960A1 (en) * | 2001-02-23 | 2002-09-06 | Glaxosmithkline Biologicals S.A. | Influenza vaccine formulations for intradermal delivery |
| EP2281573A3 (en) | 2001-02-23 | 2011-12-07 | GlaxoSmithKline Biologicals s.a. | Influenza vaccine formulations for intradermal delivery |
| ES2525518T3 (es) * | 2005-11-01 | 2014-12-26 | Novartis Vaccines And Diagnostics Gmbh | Vacunas virales derivadas de células con niveles reducidos de ADN celular residual |
| CA2628152C (en) | 2005-11-04 | 2016-02-02 | Novartis Vaccines And Diagnostics S.R.L. | Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture |
| PE20090146A1 (es) * | 2007-04-20 | 2009-03-23 | Glaxosmithkline Biolog Sa | Composicion inmunogenica contra el virus influenza |
| JP5518041B2 (ja) * | 2008-03-18 | 2014-06-11 | ノバルティス アーゲー | インフルエンザウイルスワクチン抗原の調製における改良 |
| CA2797059A1 (en) | 2010-05-03 | 2011-11-10 | Glaxosmithkline Biologicals S.A. | Novel method |
| US9426989B2 (en) | 2010-05-06 | 2016-08-30 | Novartis Ag | Organic peroxide compounds for microorganism inactivation |
| CN103370072B (zh) * | 2010-12-15 | 2016-02-03 | 巴克斯特国际公司 | 使用改进的溶剂-清洁剂方法进行病毒灭活 |
| CN102690334A (zh) * | 2011-03-21 | 2012-09-26 | 王一丁 | 一种病毒类疫苗的纯化方法 |
| CN103827296B (zh) * | 2011-07-20 | 2016-11-16 | 雅培生物学有限责任公司 | 用于产生病毒抗原和疫苗的方法 |
| WO2013173256A2 (en) * | 2012-05-16 | 2013-11-21 | Kj Biosciences, Llc | New and improved influenza vaccines |
| JP7403733B2 (ja) * | 2017-09-04 | 2023-12-25 | 国立感染症研究所長 | インフルエンザｈａスプリットワクチンの製造方法 |
| WO2019045090A1 (ja) * | 2017-09-04 | 2019-03-07 | 公益財団法人ヒューマンサイエンス振興財団 | インフルエンザｈａスプリットワクチンの製造方法 |
| CA3107409A1 (en) * | 2018-07-23 | 2020-01-30 | Japan As Represented By Director General Of National Institute Of Infectious Diseases | Composition containing influenza vaccine |
| EA202192398A1 (ru) * | 2019-03-04 | 2021-11-23 | Джэпэн Эз Репризентид Баи Директор Дженерал Оф Нэшнл Инститьют Оф Инфекшес Дизизис | Способ приготовления сплит-вакцины против гриппа на основе гемагглютинина |
-
2020
- 2020-11-06 KR KR1020227018894A patent/KR20220098370A/ko active Pending
- 2020-11-06 CN CN202080092259.7A patent/CN114929270A/zh active Pending
- 2020-11-06 US US17/771,625 patent/US20230220356A1/en active Pending
- 2020-11-06 WO PCT/IB2020/000961 patent/WO2021090067A2/en not_active Ceased
- 2020-11-06 AU AU2020380604A patent/AU2020380604A1/en active Pending
- 2020-11-06 MX MX2022005513A patent/MX2022005513A/es unknown
- 2020-11-06 BR BR112022008711A patent/BR112022008711A2/pt unknown
- 2020-11-06 EP EP20830297.6A patent/EP4054630A2/en active Pending
- 2020-11-06 JP JP2022525700A patent/JP2023500873A/ja active Pending
-
2022
- 2022-05-02 IL IL292699A patent/IL292699A/en unknown
- 2022-05-04 CL CL2022001176A patent/CL2022001176A1/es unknown
-
2025
- 2025-03-26 JP JP2025052605A patent/JP2025092571A/ja active Pending
- 2025-08-22 CL CL2025002531A patent/CL2025002531A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0870508B1 (en) | Influenza vaccine | |
| CN107567496B (zh) | 有关病毒的无菌纯化方法 | |
| IL194629A (en) | Purification processes for isolation of pure vascular stomatitis from cell culture | |
| US12305198B2 (en) | Virus purification and formulation process | |
| KR19990036028A (ko) | 일본뇌염 백신의 공업적인 생산방법 및 이에 의한 백신 | |
| CN111920944B (zh) | 一种流感病毒亚单位疫苗原液制备方法 | |
| CN110241093A (zh) | 一种重组痘病毒的纯化方法 | |
| US4206014A (en) | Process for removing detergents from virus-antigen suspensions | |
| JP2017524360A (ja) | 細胞培養体からのポリオウイルスの精製プロセス | |
| CN114181300A (zh) | 一种高纯度单克隆抗体的制备方法 | |
| JP2023500873A5 (https=) | ||
| JP3724821B2 (ja) | Ａ型肝炎（ｈａｖ）の抗原およびワクチンの製造方法 | |
| CN111575249B (zh) | 新型冠状病毒Vero细胞灭活疫苗病毒液的纯化方法 | |
| Gashti et al. | Purification of recombinant vesicular stomatitis virus-based HIV vaccine candidate | |
| CN114106114B (zh) | 利用离子交换层析纯化口蹄疫病毒抗原的方法 | |
| GB2038179A (en) | Meningo-encephalitis virus vaccines | |
| CN109134622A (zh) | 口蹄疫病毒抗原的多步连续集成纯化方法 | |
| JP2023500873A (ja) | 低減した粒度を有するウイルスワクチンを生成するための組成物および方法 | |
| KR101825996B1 (ko) | 인유두종 바이러스의 바이러스 유사 입자 제조방법 | |
| Aasletad et al. | Recovery of protective activity in rabies virus vaccines concentrated and purified by four different methods | |
| CN120192936A (zh) | 一种高剂量流感病毒裂解疫苗原液的制备方法 | |
| De Martinez Segovia et al. | Purification of Junin virus by an aqueous biphasic polymer system | |
| Weigel | Development of chromatography-based purification processes for cell culture-derived influenza virus particles | |
| CN117487769A (zh) | 一种规模化鸡胚源病毒纯化方法及其应用 | |
| Aiyedebinu | Circumvention of bottlenecks in the manufacture of influenza subunit vaccines using aqueous two-phase systems |